Rapid Acting Antidepressants: Advances in Pharmacology, cartea 89
Ronald S. Duman, John H. Krystalen Limba Engleză Hardback – 26 iun 2020
- Includes the authority and expertise of leading contributors in pharmacology
- Presents the latest release in the Advances in Pharmacology series
Din seria Advances in Pharmacology
- 29%
Preț: 1291.74 lei - 29%
Preț: 1099.26 lei - 29%
Preț: 1099.26 lei - 32%
Preț: 1144.44 lei - 33%
Preț: 1099.26 lei - 27%
Preț: 946.81 lei - 5%
Preț: 1236.44 lei - 5%
Preț: 438.32 lei - 27%
Preț: 946.55 lei - 5%
Preț: 400.40 lei - 5%
Preț: 1231.57 lei - 32%
Preț: 1033.18 lei - 33%
Preț: 1163.39 lei - 33%
Preț: 1103.94 lei - 32%
Preț: 1109.69 lei - 35%
Preț: 1099.11 lei - 35%
Preț: 1061.89 lei - 32%
Preț: 1151.76 lei - 35%
Preț: 1103.72 lei - 32%
Preț: 1107.42 lei - 33%
Preț: 1103.42 lei - 32%
Preț: 1108.97 lei - 33%
Preț: 1104.52 lei - 33%
Preț: 1103.68 lei - 29%
Preț: 1101.18 lei - 32%
Preț: 1146.75 lei - 32%
Preț: 1147.51 lei - 28%
Preț: 1183.07 lei - 27%
Preț: 1238.08 lei - 29%
Preț: 1102.47 lei - 20%
Preț: 1244.00 lei - 19%
Preț: 1250.10 lei - 29%
Preț: 1105.92 lei - 29%
Preț: 1104.88 lei - 29%
Preț: 1105.34 lei - 28%
Preț: 1149.25 lei - 28%
Preț: 1107.54 lei - 29%
Preț: 1102.55 lei - 28%
Preț: 1150.59 lei
Preț: 1184.19 lei
Preț vechi: 1816.83 lei
-35%
Puncte Express: 1776
Carte tipărită la comandă
Livrare economică 22 august-05 septembrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780128201893
ISBN-10: 0128201894
Pagini: 402
Dimensiuni: 152 x 229 mm
Greutate: 0.71 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology
ISBN-10: 0128201894
Pagini: 402
Dimensiuni: 152 x 229 mm
Greutate: 0.71 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology
Public țintă
investigators in neuroscience, pharmacology, neurology, psychiatry, medicine.Cuprins
Part I – Neurobiology of ketamine effects
- Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmissionAllie J. Widman and Lori L. McMahon
- Antidepressant mechanisms of ketamine: Focus on GABAergic inhibitionBernhard Luscher, Mengyang Feng and Sarah J. Jefferson
- The role of eEF2 kinase in the rapid antidepressant actions of ketamineKanzo Suzuki and Lisa M. Monteggia
Part II – The rapid therapeutic effects of ketamine - Clinical overview of NMDA-R antagonists and clinical practicePasha A. Davoudian and Samuel T. Wilkinson
- Ketamine for depression clinical issuesSyed Z. Iqbal and Sanjay J. Mathew
- Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidenceLynnette A. Averill, Samar Fouda, James W. Murrough and Chadi G. Abdallah
- Neurobiological biomarkers of response to ketamineBashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus and Carlos A. Zarate Jr
- Relapse prevention in treatment resistant major depressive disorder with rapid-acting antidepressantsJaskaran B. Singh, Maggie Fedgchin, Ella J. Daly and Wayne C. Drevets
- The emergence of ketamine as a novel treatment for posttraumatic stress disorderAdriana Feder, Sarah B. Rutter, Daniela Schille and Dennis S. Charney
Part III – Novel rapid-acting antidepressant mechanisms related to ketamine - mGlu2/3 receptor as a novel target for rapid acting antidepressantsShigeyuki Chaki
- Involvement of muscarinic receptor mechanisms in antidepressant drug actionJeffrey M. Witkin, Jodi L. Smith, Lalit K. Golani, Emily A. Brooks and Anna E. Martin
- The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions